Although previous research has shown the benefit of continuous glucose monitoring (CGM) for hepatic glycogen storage diseases (GSDs), current lack of prospectively collected CGM metrics and glycemic targets for CGM-derived outcomes in the hepatic GSD population limits its use.

A prospective study on continuous glucose monitoring in glycogen storage disease type Ia: towards glycemic targets / Rossi, Alessandro; Venema, Annieke; Haarsma, Petra; Feldbrugge, Lude; Burghard, Rob; Rodriguez-Buritica, David; Parenti, Giancarlo; Oosterveer, Maaike H; Derks, Terry G J. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - (2022). [10.1210/clinem/dgac411]

A prospective study on continuous glucose monitoring in glycogen storage disease type Ia: towards glycemic targets

Rossi, Alessandro;Parenti, Giancarlo;
2022

Abstract

Although previous research has shown the benefit of continuous glucose monitoring (CGM) for hepatic glycogen storage diseases (GSDs), current lack of prospectively collected CGM metrics and glycemic targets for CGM-derived outcomes in the hepatic GSD population limits its use.
2022
A prospective study on continuous glucose monitoring in glycogen storage disease type Ia: towards glycemic targets / Rossi, Alessandro; Venema, Annieke; Haarsma, Petra; Feldbrugge, Lude; Burghard, Rob; Rodriguez-Buritica, David; Parenti, Giancarlo; Oosterveer, Maaike H; Derks, Terry G J. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - (2022). [10.1210/clinem/dgac411]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/890784
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 9
social impact